INTRODUCTION
Human leukocyte antigen (HLA) class II genes were originally described as genes involved in immune response because different alleles of these genes are known to 1 influence antibody production . Studies have associated these alleles with diseases of the immune system, such as 2 3 leukemia and vitiligo . Moreover, population studies have reported the association of certain HLA alleles with susceptibility or resistance to infectious diseases, including 4 5 6 leprosy , mucosal leishmaniasis , tuberculosis and 7 hepatosplenomegaly in schistosomiasis . Few studies have examined the influence of HLA alleles on immunity to malaria. The authors of two studies (published in 1989) were unable to establish a relationship between the HLA-DR types and the immune response to circumsporozoite 8 protein (CSP) of Plasmodium falciparum and to sporozoite 9 and gametocytes epitopes in Papua New Guinea . However, two years later, protection against severe P. falciparum malaria was found to be associated with the presence of the HLA-Bw53, DRB1*1302 and DQB1*0501 10 st alleles in African children . By the turn of the 21 century, doi: 10.5123/S2176-62232010000400008
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some HLA-DR alleles had been associated with an increased antibody response to Nt47 (p126 amino- 11 terminal portion) , to apical membrane antigen-1 (AMA- 12 1) of P. falciparum and to the VK247 CSP repetition of P. 13 vivax .
The majority of studies investigating the influence of HLA alleles on the immune response to malaria have been conducted with P. falciparum antigens because of the higher mortality attributed to malaria caused by this parasite. However, P. vivax is the species responsible for the majority of malaria cases in South and Central America. In Brazil, this species accounts for more than 80% of the 14 clinical cases reported in the Amazon Region . Thus, it is important to understand the factors that control the immune response to vaccine candidate antigens, such as the asexual-blood stage proteins of P. vivax, in Brazilian people naturally exposed to the parasite. In this study, we evaluated the HLA-DRB1 allelic frequency in samples from individuals infected with P. vivax and from healthy blood donors in malaria endemic areas of Brazil.
MATERIALS AND METHODS

STUDY SUBJECTS AND LOCATIONS
The patients who were enrolled in this study met the following criteria: they sought medical assistance for clinical malaria symptoms, were over 18 years old and had a positive P. vivax malaria diagnosis by thick blood film. Signed, written informed consent was obtained before peripheral blood samples were collected from each patient. The study subjects were distributed among four Subjects in the control group were blood donors who, according to the Brazilian blood bank policy and the inclusion requirements for this study, met the following criteria: they were over 18 years old; their place of birth was within the study area; they reported never having suffered from malaria attacks and had no signs of malaria during the initial interview; and they had negative results for thick blood film. Molecular diagnosis methods were used for HLA-DRB frequency comparisons. The subjects of the two groups showed no statistically significant differences in mean age or ethnicity, indicating a well-matched population (Fisher's exact test, p > 0.05). DNA samples were extracted from frozen peripheral blood, using the TM Easy-DNA extraction kit (Invitrogen, Carlsbad, CA, USA); malaria diagnosis was confirmed using a semi-nested polymerase chain reaction (PCR) with specific small-subunit 
HLA CLASS II ALLELES
DNA samples from the malaria patients (n = 73) and the control group (n = 29) were subjected to genotyping of the HLA-DRB1 alleles. The DNA concentration was measured using a spectrophotometer at 260 and 280 nm, and a concentration of 100 ng/mL was used for lowresolution genotyping of HLA-DRB1 by PCR with sequence-specific primers (PCR-SSP), as previously 16 described .
STATISTICAL ANALYSIS
Allele frequencies were calculated with the formula AF = a/N, in which a represents the number of positive samples for a specific allele and N represents the total 17 number of alleles in the study population . R version 2.8.1 statistical software (The R Foundation for Statistical Computing, Vienna, Austria, http://www.r-project.org) was used for the statistical analyses. The Hardy-Weinberg 18 equilibrium was tested according to Guo and Thompson . The heterogeneity of HLA allelic frequencies between control and malaria-infected groups was evaluated using a Chi-square analysis, with Yate's correction test or Fisher's exact test. P-values less than 0.05 were considered statistically significant.
RESULTS
HLA-DRB1 genotyping was performed in a total of 102 individuals, including malaria-infected individuals and uninfected controls, from four endemic areas in the north of Brazil. As summarized in table 1, 13 different alleles were found; the frequencies observed for each individual and for each group are also described in table 1. The most frequent alleles for both groups were HLA-DRB1*04, *08, *07 and *13. In malaria-infected individuals, HLA-DRB1*04, *08 and *13 were the most frequent alleles, followed by HLA-DRB1*07. In the control group, HLA-DRB1*04, *08 and *13 were also the most frequent, but HLA-DRB1*07 was one of the least frequent alleles in this group. When we compared the malaria-infected group with the control group, the HLA-DRB1*07 frequency was higher in the infected group than in the control group; this difference was statistically significant (p = 0.006, Chi-square test with Yate's correction). The loci were in Hardy-Weinberg 2 equilibrium in the studied population (Pearson's x = 0.5, p = 0.799). malaria, has been documented . Moreover, ethnic and/or geographic variations apparently play a major role in this correlation. The nation of Brazil is as large as an entire continent, and its inhabitants are genetically diverse. This diversity results in a mixed population formed by the contributions of three important groups: 19 Caucasians, Africans and Amerindians . Due to the diverse history of colonization, different regions of the country have different levels of prevalence of the three 20, 21 ethnic groups . We found a high frequency of HLA-DRB1*04 in our subjects, which is similar to the results seen 22, 23 in previous studies . Because this allele is characteristic of indigenous Americans, its prevalence reflects the Amerindian contribution to the Brazilian population, 24 especially in the north of the country . Additionally, the high frequency of HLA-DRB1*04 that was observed in both malaria-infected and healthy individuals indicates that this allele is not associated with susceptibility to or protection from P. vivax malaria. On the other hand, the significantly higher frequency of the HLA-DRB1*07 in the infected group suggests a role for this allele in susceptibility to 13 malaria. Oliveira-Ferreira et al detected a poor immune response induced by HLA-DRB1*07 against the VK210 repetitive region of P. vivax CSP. In fact, studies with viral 22,25 26 vaccine and vaccine trials with CSP of P. falciparum have shown that this allele fails to trigger a consistent immune response.
Although differences have been observed in the HLA-DRB1*07 frequencies between malaria-infected and uninfected individuals, we have not established a mechanism by which this allele may function in malaria susceptibility. There may be multiple HLA molecules associated with human malaria, although we were only able to analyze the HLA-DRB1 alleles in this study. Analysis of a single HLA molecule cannot fully reflect how multiple genetic variations impact the MHC region. One possibility is that MHC alleles could be in linkage disequilibrium with other relevant genes involved in susceptibility to P. vivax malaria. Additionally, patients homozygous for the HLA-DRB1*07 allele could not be distinguished from carriers due to the sampling limitations of this study.
In the Brazilian Amazon Region, malaria predominates in mesoendemic conditions with a wide variation in 14, 27 transmission . Thus, malaria endemicity could be viewed as a selective pressure for maintenance of the genotype frequencies of the HLA molecules. Investigation of other malaria-associated HLA alleles, using serological, clinical and epidemiological analysis of a large sample size, is necessary. Such a study should also evaluate the influence of other infectious diseases. The epidemiology of infectious diseases is conditioned by a complex interrelationship between the parasite, its vector and the human being. The parasite-host coevolutionary process can be viewed as an arms race, in which adaptive genetic changes in one are eventually matched by alterations in the other, in this case, within the genetically diverse Amazonian 28 populations .
CONCLUSION
We found that the HLA-DRB1*07 allele frequency was higher in malaria patients than in the control group, which could suggest a role for this allele in susceptibility of the immune system to P. vivax malaria. Our results reinforce the need for studies that focus on genes linked to the histocompatibility complex; there is a particular need for studies using a larger sample size, as well as individuals from areas with different rates of infection, to better establish the role of the HLA in susceptibility to P. vivax parasites in this region.
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To all individuals enrolled in this study. We thank Drs. Carlos Eugênio Cavasini, Aline Barroso, Maria Cristina Figueredo and Mauro Tada for helping in the malaria field work. To Juliana Cintra for assistance in HLA genotyping analysis. To Dr. Antônio José Cordeiro for his participation in statistical analysis. To Professor Luiz Hildebrando Pereira da Silva for allowing the use of all facilities at Centro de Pesquisas em Medicina Tropical (Cepem). Frequência de polimorfismos HLA-DRB1 em pacientes brasileiros com malária por Plasmodium vivax e em doadores de sangue da Região Amazônica RESUMO Este estudo avaliou a frequência de diferentes alelos HLA-DRB1 em indivíduos infectados por Plasmodium vivax e em doadores de sangue saudáveis provenientes de áreas endêmicas de malária do Brasil. Foi realizada uma genotipagem de baixa resolução dos alelos HLA-DRB1 em 73 pacientes com malária e em 29 doadores de sangue saudáveis. Os alelos mais frequentes em indivíduos do norte do Brasil foram HLA-DRB1 *04, *08, *07 e *13. A frequência de HLA-DRB1 *07 foi maior nos indivíduos infectados com malária do que no grupo controle, o que reforça a hipótese de que esse alelo desempenha um papel importante na suscetibilidade à malária. Esta pesquisa fornece novas informações sobre um fator potencial de suscetibilidade à malária por P. vivax em uma população brasileira naturalmente exposta à doença.
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Frecuencia de polimorfismos HLA-DRB1 en pacientes brasileños con malaria por Plasmodium vivax y en donantes de sangre de la Región Amazónica RESUMEN Este estudio evaluó la frecuencia de diferentes alelos HLA-DRB1 en individuos infectados por Plasmodium vivax y en donantes de sangre saludables provenientes de áreas endémicas de malaria de Brasil. Se realizó un genotipado de baja resolución de los alelos HLA-DRB1 en 73 pacientes con malaria y en 29 donantes de sangre saludables. Los alelos más frecuentes en individuos del norte de Brasil fueron HLA-DRB1 *04, *08, *07 y *13. La frecuencia de HLA-DRB1 *07 fue más grande en individuos infectados con malaria que en el grupo control, lo que refuerza la hipótesis de que ese alelo desempeña un papel importante en la susceptibilidad a la malaria. Esta investigación suministra nuevas informaciones sobre un factor potencial de susceptibilidad a la malaria por P. vivax en una población brasileña naturalmente expuesta a la enfermedad. 
